BioSpace News Archive

Precigen, Inc. today announced that the Company will host a virtual event on Thursday, November 4, 2021 at 11:00 AM ET

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the exercise of its option to acquire GammaDelta Therapeutics Limited (“GammaDelta”), a company focused on exploiting the unique properties of gamma delta (γδ) T cells for immunotherapy.

Monteris Medical, the leader in MR-guided laser interstitial thermal therapy (LITT or laser ablation), announced today that Cigna, a global health services company and one of the largest commercial payors in the United States, has released a national coverage policy supporting the use of LITT for people with brain tumors and drug-resistant epilepsy.

The approval follows the U.S. Food and Drug Administration (FDA) providing clearance to proceed with the Company’s Investigational New Drug (IND) application to commence this trial, as announced by the Company on August 24th, 2021.

Halberd Corporation (OTC Pink: HALB) announces the filing of a provisional patent application with the US Patent and Trademark Office covering their extracorporeal removal from the blood of patients of the various proteins, cytokines and antigens associated with obesity.

Aston Sci., a portfolio model biopharmaceutical company, announced that the study results of its therapeutic cancer vaccine pipelines, AST-301 and AST-021p, will be presented at the Society for Immunotherapy of Cancer(SITC) in November.

South Korea’s leading molecular diagnostics (MDx) developer Seegene Inc., (KQ 096530) is addressing the needs of small, mid-sized, and large hospitals and COVID-19 laboratories with its fully automated STARlet-AIOS: All-in-One System (AIOS).

Iotron Medical Inc. (Iotron) is pleased to announce the appointment of Patrick Donahue as its CEO effective immediately.

TELA Bio, Inc. (“TELA”), today announced that the company will report third quarter 2021 financial results on Wednesday, November 10, 2021.

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it plans to release its third quarter 2021 financial results after the market closes on Wednesday, November 10, 2021.